BPC-157 Guide: Uses, Evidence & Legal Status| BonesLabs

Key takeaways

– The evidence base is overwhelmingly preclinical: a 2025 systematic review in *HSS Journal* screened 544 articles and included 36 studies — 35 preclinical (mostly rats) and only 1 clinical.

– BPC-157 is **not FDA-approved** for human use and was named an FDA **Category 2** bulk drug substance in 2023, meaning it cannot be lawfully compounded.

– It is **banned in sport** by WADA (category S0) and is on the U.S. Department of Defense Prohibited Dietary Supplement Ingredients List.

– This page is educational. BonesLabs sells research compounds **for laboratory research use only — not approved for human consumption**.

BPC-157: What It Is, What the Evidence Shows, and Its Legal Status

BPC-157 is a synthetic 15-amino-acid peptide (“body protection compound”) studied mainly in animals for tissue and tendon healing. It is not approved by the FDA for any human use, is sold for research use only, and has been on the World Anti-Doping Agency (WADA) Prohibited List under category S0 (non-approved substances) since 2022. Human clinical evidence is minimal but ongoing trials show potentially promising future for patients with knee pains.

BPC-157 is a lab-synthesized pentadecapeptide based on a fragment of a protein found in human gastric juice. The 15-amino-acid fragment itself does not occur naturally. For context, the body body naturally produces Body Protection Compound (BPC), BPC-157 is a laboratory-cleaved, 15-amino-acid synthetic fragment (pentadecapeptide) of that parent protein

---

What is BPC-157?

BPC-157 is a synthetic peptide made of 15 amino acids (a “pentadecapeptide”). Its name stands for “body protection compound,” and it is derived from a partial sequence of a protein originally isolated from human gastric juice. According to laboratory characterizations, the synthesized fragment does not occur as such in nature and is produced in the lab. https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2021.627533/full

A commonly reported feature in the literature is its unusual stability: BPC-157 has been described as remaining intact in human gastric juice for an extended period in laboratory conditions. Preclinical and laboratory studies show BPC-157 remains intact for over 24 hours in acidic and enzymatic conditions. 

In animal models, BPC-157 has been studied for healing of tendon, muscle, ligament, and bone injuries, and for gastrointestinal protection. A 2025 systematic review in *HSS Journal* (Vasireddi et al.) reported that across preclinical muscle, tendon, ligament, and bone injury models, outcomes consistently showed improved functional, structural, and biomechanical results, linked to growth-factor upregulation and angiogenesis.

Importantly, that same review included **35 preclinical studies and just 1 clinical study** across all musculoskeletal applications — and the single clinical reference was a small retrospective case series of intra-articular injections for chronic knee pain, not a controlled trial. This is the core caveat: promising animal data has not been confirmed by rigorous human trials.

Earlier preclinical work, such as a study published in the *Journal of Orthopaedic Research*, reported that BPC-157 accelerated healing of transected rat Achilles tendon and stimulated tendocyte growth in vitro.

---

Is BPC-157 FDA-approved?

No. BPC-157 is **not approved by the FDA for any human indication**. As of April 2026, the FDA delisted BPC-157 as a **Category 2** bulk drug substance for compounding. A Category 2 designation means there is significant safety risk and the substance cannot lawfully be used in compounded preparations.

---

Is BPC-157 legal to buy or use?

BPC-157 is not a dietary ingredient and is described by Operation Supplement Safety (OPSS), a U.S. Department of Defense program, as an **unapproved drug** that cannot be legally prescribed or sold over the counter for human use. It is also listed on the DoD Prohibited Dietary Supplement Ingredients List.

It is, however, sold and shipped legally as a research chemical for **laboratory research use only**. BonesLabs supplies BPC-157 strictly on that basis — not for human or veterinary consumption.

What’s the verdict, Is BPC-157 safe?

There is not enough human data to establish safety. The 2025 *HSS Journal* review noted favorable preclinical toxicology (no LD50 identified in animal testing) and rapid metabolism, but it did **not** establish human safety, and the FDA’s Category 2 designation explicitly reflects insufficient evidence on whether BPC-157 could cause harm in humans.

A further risk is product quality: peptides sold outside regulated channels may be mislabeled, underdosed, or contaminated. FDA warning letters and found that 89.36% of compounding facility citations included failures in adequate labeling/incorrect ingredient amounts declared, and 73.05% cited misbranded drug products overall